
Parissa Tabrizian MD
Transplantation
Associate, Surgery, Icahn School of Medicine at Mount Sinai
Join to View Full Profile
5 E 98th StNew York, NY 10029
Phone+1 212-659-8084
Fax+1 646-537-9238
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Parissa Tabrizian, MD is a general surgeon in New York, New York. She is currently licensed to practice medicine in New York. She is an Associate at Icahn School of Medicine at Mount Sinai.
Education & Training
- Icahn School of Medicine at Mount SinaiResidency, Surgery, 2005 - 2006
- University of Vienna Faculty of MedicineClass of 2002
Certifications & Licensure
- NY State Medical License 2011 - 2026
- American Board of Surgery Surgery
Publications & Presentations
PubMed
- Sociodemographic disparities in downstaging to liver transplant for hepatocellular carcinoma.Kali Zhou, Lauren Nguyen, Parissa Tabrizian, Neil Mehta
Liver Transplantation. 2025-04-01 - 8 citationsIntention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: The multicenter VITALITY study.Parissa Tabrizian, Matthew L Holzner, Veeral Ajmera, Amy K Kim, Kali Zhou
Journal of Hepatology. 2025-03-01 - Predicting futile outcomes following deceased donor liver transplantation in non-Hcc patients with MELD-Na score above 30: a retrospective international multicenter co...Hye-Sung Jo, Young-In Yoon, Ki-Hun Kim, Parissa Tabrizian, Rebecca Marino
International Journal of Surgery. 2025-02-05
Press Mentions
- Immunotherapy Shows Promise in Downstaging Liver Tumors Prior to TransplantNovember 19th, 2024
- "Downstaging" Liver Cancer Before Transplant Improves OutcomesJuly 25th, 2022
- Shrinking Liver Cancer Tumors Before Transplant Yields Excellent Outcomes, Mount Sinai Researchers ReportJuly 20th, 2022